A device for treating leakage from an external orifice in the body of a patent which comprises a first member having a body-contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the patient with said aperture positioned over said orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid to flow through said aperture when desired, the closed and open positions being achievable without removing the device from the body of the patient.

Patent
   6461291
Priority
Dec 04 1997
Filed
Apr 28 2000
Issued
Oct 08 2002
Expiry
Dec 04 2017
Assg.orig
Entity
Large
11
51
all paid
2. A device for alleviating urinary incontinence in a patient having a urethra and an external urethral orifice, which device comprises:
a first member having a body-contacting first surface and an opposing second surface situated about an aperture, which first surface is attachable to the patient with said aperture positioned over the patient's urethral orifice and without any structure of the device projecting into the patient's urethra, and
a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of urine through the device and an open position which allows urine from the urethral orifice to flow through said aperture upon micturition, the closed and open positions being achievable without removing the device from the patient.
1. A device for restricting leakage from an external orifice of a patient's urethra, which device comprises:
a body-contacting first surface, and
an opposing second surface situated about an aperture, which first surface is attachable to an external surface of the patient with said aperture positioned over the orifice of the urethra so that the device may be associated with the patient without any structure projecting into the urethra of the patient, and
a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid from the orifice of the urethra to flow through said aperture when desired,
the closed and open positions being achievable without removing the device from the body of the patient.
3. A device according to claim 2, in which at least a portion of said first surface is coated with a biologically-compatible adhesive to facilitate attachment of the surface to the body of the patient.
4. A device according to claim 2 for alleviating urinary incontinence in a female patient, in which said first member is a substantially circular or oval shaped flange having an adhesive-coated first surface which is attachable to the floor of the labial vestibule, and said valve is defined by a foldable extension of the flange, which extension comprises two foldable flaps having a closed position wherein the flaps are folded inwardly to form a closure over the aperture and an open position wherein the flaps extend outwardly to define a flow path from the aperture to the exterior.
5. A device according to claim 4, in which the foldable flaps of the valve are made from a biologically compatible elastomer.
6. A device according to claim 5, in which the flange and flaps are integral with each other and are made from the same elastomer.
7. A device according to claim 4, in which the aperture has a funnel shaped wall which narrows to a neck having two sides, each of which acts as a pincher to close the valve and the valve is defined by a foldable extension of the flange which comprises two foldable flaps each comprising a dome portion and a duct portion, which duct portion is defined by side walls, wherein the flaps fold inwardly and said side walls are pinched by the pinchers to close the duct and form a closure which prevents flow of urine outwardly through the aperture.
8. A device according to claim 7, in which each foldable flap terminates in a grippable end piece which is pushed inwardly by the patient to close the valve and pulled outwardly to open the valve and provide a flow channel through the duct to aglow micturition.
9. A modification of the device according to claim 7, in which each pincher terminates in a snapper which snaps into a groove in the side wall of the duct when the valve is closed and each snapper is withdrawn from each groove to open the valve and allow micturition.
10. A modification of the device according to claim 9, in which each pincher comprises a wing-shaped portion which includes a snapper whereby the closed position of the valve is achieved by squeezing the wing-shaped portions so that each snapper snaps into a groove in the dome portion and the pinchers close the duct portion, and the open position is achieved by pushing the wing portions outwardly.

This application is a continuation of U.S. application Ser. No. 08/984,976, filed Dec. 4, 1997, now U.S. Pat. No. 6,056,687.

This invention relates to a device for alleviating urinary incontinence. More particularly, the invention is concerned with a device which facilitates control of urination by preventing undesirable leakage of urine and yet allowing micturition when required without removal of the device from the body of the patient. A most preferred embodiment of the device is for alleviating urinary incontinence. particularly stress incontinence, in a female patient. An embodiment for use with a male patient is also included. A further embodiment for dealing with leakage from a body stoma is also contemplated.

Urinary incontinence, which is a condition involving involuntary loss of urine, is a problem with very many patients, particularly female patients, throughout the world. Sometimes the problem is treated with surgery. However, when the patient can not receive surgery or suffers only from a partial loss of urine, the problem may be treated non-surgically by use of an internal (intra-urethral or intra-vaginal) or external device. A number of external female devices have been proposed in the art.

For example, U.S. Pat. No. 5,074,855 discloses a device for controlling urinary incontinence in a human female comprising a resilient pad configured to seal against and occlude the urethral meatus of the user. A similar device is disclosed in U.S. Pat. No. 5,336,208. In both these devices, an adhesive is provided to seal the body of the device against the urethral meatus.

International Applications No. 96/39989, 96/39990 and 96/39991 each disclose a adfemale urinary incontinence device in the form of a urethral cap with a partially deformable body portion, a hand gripping portion and a body contacting surface. The body portion defines a chamber which allows for a vacuum seal when applied to the patient's body.

Each of the above devices prevents urinary leakage by occluding the external urethral orifice and each has to be removed by the patient to allow micturition.

It is desirable to have a device which satisfactorily prevents leakage and also facilitates micturition without the need to remove the device from the body of the patient. It has now been found that these desiridata may be achieved by a device which incorporates an easily operable valve which prevents leakage when closed and allows flow when open.

According to the invention there is provided a device for treating leakage from an external orifice in the body of a patient, which device comprises a first member having a body contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the body of the patient with- said aperture positioned over said orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of fluid through the device and an open position which allows fluid from said orifice to flow through said aperture when desired, the closed and open positions being achievable without removing the device from the body of the patient.

When the external orifice is a urethral orifice the fluid is urine and accordingly the invention provides, as a preferred embodiment, a device for alleviating urinary incontinence in a patient having an external urethral orifice, which device comprises a first member having a body-contacting first surface and an opposing second surface about an aperture, which first surface is attachable to the patient with said aperture positioned over said urethral orifice, and a second member integral with said second surface, which second member comprises a valve mounted over said aperture, which valve has a closed position which prevents leakage of urine through the device and an open position which allows urine from said urethral orifice to flow through said aperture upon micturition, the closed and open positions being achievable without removing the device from the patient.

In a further preferred embodiment at least a portion of said first surface is coated with a biologically-compatible adhesive, i.e. a medical adhesive, to facilitate attachment of the surface to the body, e.g. the floor of the labial vestibule around the urethral meatus, of the patient.

A particularly preferred embodiment of the invention is a device as described above for alleviating urinary incontinence in a female patient, in which said first member is a substantially circular or oval shaped flange having a first surface at least a portion of which is coated with a biologically-compatible adhesive so that said first surface is attachable to the floor of the labial vestibule, and said valve is defined by a foldable extension of the flange, which extension forms two foldable flaps having a closed position wherein the flaps are folded inwardly to form a closure over the aperture and an open position wherein the flaps extend outwardly to define a flow path from the aperture to the exterior.

The valve of the invention may have any one of a number of different configurations.

In each preferred version of the valve, the aperture is preferably funnel-shaped and the wall of the funnel is defined by the first surface of the flange. However, the positioning of the portions of the flange which act upon the foldable flaps to effect closure of the valve, each of which is herein designated as a "pincher", relative to the other portions, differs in the various versions. The configuration of the portions which make up the valve and the foldable flaps thereof and the spatial relationship of these portions with respect to each other is described in detail hereinafter with reference to the embodiments illustrated in the accompanying drawings.

Each foldable flap of the valve is preferably made of a material which is sufficiently elastic to be folded and compressed or pinched a number of times without deterioration and the preferred material is a biologically compatible elastomer. Typically all components of the device are integral with each other and are made from the same elastomeric material.

A device suitable for a male patient is also included within the invention, and in this embodiment the first member will have the shape of a short condom instead of a flange.

Additionally the invention also encompasses an embodiment which may be used to control leakage from a body stoma and allow drainage therefrom when desired. The components of such an embodiment are analogous to those of the herein described embodiments for alleviating urinary incontinence.

The device of the invention will be particularly described with reference to preferred embodiments illustrated in the accompanying drawings, in which:

FIG. 1 is a schematic side elevation of a first embodiment of the invention showing the valve in the closed position;

FIG. 2 is a section through line II--II of FIG. 1;

FIG. 3 is a section through the closed duct of the valve;

FIG. 4 is a schematic side elevation of the first embodiment showing the valve in the open position;

FIG. 5 is a section through the open duct of the valve;

FIG. 6 is a schematic side elevation of a second embodiment of the invention showing the valve in the closed position;

FIG. 7 is a top plan view through line VII of FIG. 6;

FIG. 8 is a schematic side elevation of the second embodiment showing the valve in the open position;

FIG. 9 is a schematic side elevation of a third embodiment of the invention showing the valve in the closed position;

FIG. 10 is a top plan view through line X of FIG. 9; and

FIG. 11 is a schematic side elevation of the third embodiment showing the valve in the open position.

The device illustrated in FIGS. 1-5 of the accompanying drawings is a preferred first embodiment for the alleviation of urinary incontinence in a female patient.

The device comprises a first member 1 having a body-contacting first surface 2 and an opposing second surface 3. In the embodiment illustrated the first member is a substantially circular flange, wherein at least a portion of the first surface 2 is coated with a medical adhesive. Alternatively the first member may have a substantially oval configuration or any other configuration which will facilitate placement over the urethral meatus with the minimum discomfort. The flange defines an aperture 4 which will be positioned over the urethral orifice when the first surface is attached to the patients body with the aid of the adhesive. The aperture has a funnel-shaped wall 5 which narrows to a neck 6 which acts as a pincher to close the valve as described hereinafter.

The device further comprises a second member 7 which is a valve mounted over the aperture. The valve is defined by a foldable extension of the flange which comprises two foldable flaps each comprising a dome portion 8 and a duct portion 9. As shown in FIG. 3 and FIG. 4 the duct portion is defined by side walls 10. In the closed position, as shown in FIG. 1, the flaps fold inwardly and the side walls of the duct portion are pinched by the pinchers to close the duct and form a closure which prevents flow of liquid (urine) outwardly through the aperture. Each foldable extension or flap terminates in a grippable end piece 11 which is pushed inwardly by the patient to close the valve as shown in FIG. 1 and may be pulled outwardly to open the valve as shown in FIG. 3. As illustrated in FIG. 3, when the duct portion is pulled outwardly the valve is in the open position and a flow channel or lumen 12 is provided to allow micturition.

A second embodiment of the invention is illustrated in FIGS. 6,7 and 8. This embodiment also utilizes a valve defined by foldable flaps, but the configuration thereof differs somewhat from the configuration of FIGS. 1, 2 and 3. In this second embodiment the reference numerals 1, 2, 3, 4, 5, 9,10, 11 and 12 have analogous meanings to the reference numerals identifying the features of the first embodiment However, in the second embodiment the configuration of the pinchers 16 and the foldable flaps comprising the valve 17 is somewhat different. Each pincher is still an integral extension of the flange 1, but in the second embodiment each pincher terminates in a snapper 22 which snaps into an indented portion or groove 23 (see FIG. 8) in the side wall 10 of the duct when the valve is closed. The dome 18 of each flap projects within the funnel of the aperture in contrast to the outside configuration of the first embodiment. When the valve is pushed in each snapper snaps into the groove 23 and the combination of snappers and pinchers closes the lumen 12. When the valve is opened as shown in FIG. 8 each snapper is withdrawn from each groove and the lumen opens to allow micturition.

A further variation of the invention is a third embodiment as illustrated in FIGS. 9, 10 and 11. Here again reference numerals 1, 2, 3, 4, 5, 9, 10 and 12 have analogous meanings to the reference numerals used in the previous figures. However, in the third embodiment the dome 28 has a different profile from that in the first and second embodiments and so has the pincher 26. In the third embodiment each pincher 26 comprises a wing-shaped portion which includes a snapper 32. The closed position of the valve as shown in FIG. 9 is achieved by squeezing the wing portions so that each snapper 32 snaps into a groove 33 in the dome and the pinchers close the duct portion 9. The open position is achieved by pushing the wing portions outwardly.

In each of the above-described embodiments the size of the flange is such that it may be realasably attached to the labial vestibule without discomfort to the patient The aperture should be large enough so that when it is positioned over the urethral orifice there should be sufficient clearance to facilitate micturition when desired. Typically the flange would have an external diameter of about 2 to 3 cm. depending upon the body size of the patient. The protruding dimension of the device should be no more than 1.5 to 2 cm. between the open and closed positions of the valve.

The incorporation of a valve as described above in a device according to any one of the preferred three embodiments described herein above provides a valuable means for the alleviation of urinary incontinence, particularly stress incontinence, in females, which prevents leakage and yet allows micturition when desired, with minimal discomfort and maximal ease of operation. By allowing micturition without the need to remove the device, the patient is provided with a device which is clearly advantageous over the various plugs and pads available heretofore.

The device according to the invention may be worn by the patient for as much as a whole day or even longer if the patient's condition so allows. The preferred device is intended to be disposable.

The device may be made with a type of valve other than valve as described herein: however, valves with a more complex mechanism would be more costly to produce and any valve which involves a complicated opening and closing procedure, particularly a procedure which takes more than a few seconds of time, should be avoided. Furthermore, it is important that operation of the valve should not significantly affect the attachment of the device to the body of the patent Additionally, the structure described herein may be made in one piece from the same elastomeric material, apart from the adhesive.

Thus, for the reasons of easy operation, ease of manufacture, low cost and disposability, at least, a device incorporating a valve, as herein described, is the preferred embodiment of the invention.

Polyak, Mark, Hauschild, Sidney F.

Patent Priority Assignee Title
6936052, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
6991597, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
7025772, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
7235043, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
7361138, Jul 31 2003 Boston Scientific Scimed, Inc Bioabsorbable casing for surgical sling assembly
7402133, Dec 17 2002 Boston Scientific Scimed, Inc Spacer for sling delivery system
7824326, Jul 31 2003 Boston Scientific Scimed, Inc. Bioabsorbable casing for surgical sling assembly
8033983, Mar 09 2001 Boston Scientific Scimed, Inc Medical implant
8162816, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
8617048, Mar 09 2001 Boston Scientific Scimed, Inc System for implanting an implant and method thereof
8632453, Dec 17 2002 Boston Scientific Scimed, Inc. Spacer for sling delivery system
Patent Priority Assignee Title
2510766,
3547401,
3758073,
3841304,
4210132, Jul 26 1978 The Kendall Company Artificial sphincter
4344434, Jun 01 1981 Santa Barbara Medical Foundation Clinic Ileostomy appliance and method for implanting the same
4552128, Dec 29 1983 HABLEY MEDICAL TECHNOLOGY CORPORATION, A CORP OF CA Elastomechanical sphincter
4587954, Dec 29 1983 HABLEY MEDICAL TECHNOLOGY CORPORATION, A CORP OF CA Elastomeric prosthetic sphincter
4631062, May 21 1984 Kimberly-Clark Worldwide, Inc Labial sanitary pad
4690677, Sep 25 1985 DALTEX MEDICAL SCIENCES, INC , 20 EXCHANGE PLACE, NEW YORK, NEW YORK, 10005 Urine collection system for females
4822333, Sep 02 1987 Urethral endoprosthesis
4850953, Jul 27 1987 HABLEY MEDICAL TECHNOLOGY CORPORATION, 22982 ALCALDE, A CA CORP Gastrostomy valve
4968294, Feb 09 1989 OPTICON MEDICAL INC Urinary control valve and method of using same
5074855, Jan 10 1991 Procter & Gamble Company, The Urinary incontinence pad
5082006, Sep 15 1987 JONASSON, LINDA Device for preventing involuntary micturition
5114398, Feb 27 1990 Urocath Corporation Female incontinence control device with mechanically operable valve
5140999, Sep 30 1991 Primed International Corp.; PRIMED INTERANTIONAL CORP A CORPORATION OF MN Urinary incontinence valve device
5336208, Jan 10 1991 Procter & Gamble Company, The Urinary incontinence pad
5352182, May 27 1992 Product and method to treat female incontinence
5483976, Dec 31 1990 UroMed Corporation Mechanically actuated urethral plug assembly and method for controlling urinary incontinence
5640976, Jun 06 1995 Iotek, Inc. Incontinence plug anchor
5662582, Feb 27 1995 Iotek, Inc, Everting incontinence plug
5711314, Nov 08 1996 CYSTOMEDIX, INC Urinary incontinence valve with distal and proximal anchoring means
5722931, Mar 05 1996 IMAGYN MEDICAL TECHNOLOGIES, INC Female incontinence device
5752525, Aug 16 1991 UroMed Corporation Urethral plug assembly having adhesive for enhanced sealing capabilities and method of using said plug assembly
5755236, Dec 12 1996 Female incontinence device
5813974, Dec 19 1995 Device for women suffering from incontinence
6030337, Jul 30 1998 Boston Scientific Corporation; Boston Scientific Scimed, Inc Continence augmentor and methods for urinary control
6056687, Dec 04 1997 Boston Scientific Corporation; Boston Scientific Scimed, Inc Device for alleviating urinary incontinence
6200261, Mar 04 1998 Boston Scientific Corporation; Boston Scientific Scimed, Inc Valve and methods for urinary control
EP535778,
EP780105,
WO9206731,
WO9211826,
WO9219192,
WO9308765,
WO9426915,
WO9508968,
WO9626688,
WO9639096,
WO9639989,
WO9639990,
WO9639991,
WO9706758,
WO9717909,
WO9725947,
WO9819640,
WO9825555,
WO59403,
WO151578,
WO9717909,
////////////////////////////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 17 2000AMERICAN MEDICAL SYSTEMS, INC BANK OF AMERICA, N A , AS AGENTNOTICE OF GRANT OF SECURITY INTEREST0142100936 pdf
Apr 28 2000American Medical Systems Inc.(assignment on the face of the patent)
Jul 01 2004BANK OF AMERICA, N A AMERICAN MEDICAL SYSTEMS, INC RELEASE OF SECURITY INTEREST0156210551 pdf
Jul 17 2006BANK OF AMERICA, N A , AS AGENTAMERICAN MEDICAL SYSTEMS, INC RELEASE OF SECURITY INTEREST SUPERCEEDING RELEASE RECORDED ON JULY 30, 2004 AT REEL FRAME 015621 0551 0179570644 pdf
Jul 18 2006AMERICAN MEDICAL SYSTEMS, INC AMS Research CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0179710777 pdf
Jul 20 2006AMERICAN MEDICAL SYSTEMS, INC CIT HEALTHCARE LLCSECURITY AGREEMENT0181320639 pdf
Apr 12 2011CIT HEALTHCARE LLCAMERICAN MEDICAL SYSTEMS, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0261420569 pdf
Jun 17 2011AMS Research CorporationMORGAN STANLEY SENIOR FUNDING, INC , AS ADMINISTRATIVE AGENTSECURITY AGREEMENT0266320535 pdf
Feb 28 2014MORGAN STANLEY SENIOR FUNDING, INC , AS ADMINISTRATIVE AGENTAMS Research CorporationRELEASE OF PATENT SECURITY INTEREST0323800053 pdf
Feb 28 2014ENDO PHARMACEUTICALS SOLUTIONS, INC DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENTGRANT OF SECURITY INTEREST IN PATENTS0324910440 pdf
Feb 28 2014ENDO PHARMACEUTICALS, INC DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENTGRANT OF SECURITY INTEREST IN PATENTS0324910440 pdf
Feb 28 2014LaserscopeDEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENTGRANT OF SECURITY INTEREST IN PATENTS0324910440 pdf
Feb 28 2014AMERICAN MEDICAL SYSTEMS, INC DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENTGRANT OF SECURITY INTEREST IN PATENTS0324910440 pdf
Feb 28 2014AMS Research CorporationDEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENTGRANT OF SECURITY INTEREST IN PATENTS0324910440 pdf
Dec 17 2014AMS RESEARCH CORPATIONAMS Research, LLCCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0373000318 pdf
Dec 17 2014AMS Research CorporationAMS Research, LLCCORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0318 ASSIGNOR S HEREBY CONFIRMS THE CHANGE OF NAME 0399190017 pdf
Feb 27 2015AMS Research, LLCAPHRODITE WOMEN S HEALTH, LLCASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0374730260 pdf
Aug 03 2015DEUTSCHE BANK AG NEW YORK BRANCHLaserscopeRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0362850146 pdf
Aug 03 2015DEUTSCHE BANK AG NEW YORK BRANCHAMS Research, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0362850146 pdf
Aug 03 2015DEUTSCHE BANK AG NEW YORK BRANCHAMERICAN MEDICAL SYSTEMS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0362850146 pdf
Sep 29 2015APHRODITE WOMEN S HEALTH, LLCASTORA WOMEN S HEALTH, LLCCHANGE OF NAME SEE DOCUMENT FOR DETAILS 0374730354 pdf
Dec 22 2016ENDO HEALTH SOLUTIONS INC Boston Scientific CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0437780302 pdf
Dec 22 2016Boston Scientific CorporationBoston Scientific Scimed, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0437800316 pdf
Dec 22 2016ASTORA WOMEN S HEALTH HOLDINGS, LLCBoston Scientific CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0437780302 pdf
Dec 22 2016ASTORA WOMEN S HEALTH, LLCBoston Scientific CorporationASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0437780302 pdf
Apr 27 2017ASTORA WOMEN S HEALTH, LLCWilmington Trust, National Association, as Collateral TrusteeSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0427430278 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONENDO PHARMACEUTICALS SOLUTIONS INC FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONGENERICS BIDCO I, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONGENERICS INTERNATIONAL US , INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONPAR PHARMACEUTICAL, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONPAR STERILE PRODUCTS, LLC FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONQUARTZ SPECIALTY PHARMACEUTICALS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONSLATE PHARMACEUTICALS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONEndo Pharmaceuticals IncRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONENDO GENERIC HOLDINGS, INC FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONDAVA PHARMACEUTICALS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONDAVA INTERNATIONAL, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONBIOSPECIFICS TECHNOLOGIES CORP RELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONAuxilium US Holdings, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONAUXILIUM PHARMACEUTICALS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONASTORA WOMEN’S HEALTH LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONASTORA WOMEN’S HEALTH HOLDINGS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONACTIENT PHARMACEUTICALS LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Apr 23 2024WILMINGTON TRUST, NATIONAL ASSOCIATIONVINTAGE PHARMACEUTICALS, LLCRELEASE BY SECURED PARTY SEE DOCUMENT FOR DETAILS 0672400001 pdf
Date Maintenance Fee Events
Apr 10 2006M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Mar 31 2010M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Mar 26 2014M1553: Payment of Maintenance Fee, 12th Year, Large Entity.


Date Maintenance Schedule
Oct 08 20054 years fee payment window open
Apr 08 20066 months grace period start (w surcharge)
Oct 08 2006patent expiry (for year 4)
Oct 08 20082 years to revive unintentionally abandoned end. (for year 4)
Oct 08 20098 years fee payment window open
Apr 08 20106 months grace period start (w surcharge)
Oct 08 2010patent expiry (for year 8)
Oct 08 20122 years to revive unintentionally abandoned end. (for year 8)
Oct 08 201312 years fee payment window open
Apr 08 20146 months grace period start (w surcharge)
Oct 08 2014patent expiry (for year 12)
Oct 08 20162 years to revive unintentionally abandoned end. (for year 12)